FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung Cancer By Ogkologos - January 22, 2026 379 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the DeLLphi-304 study Source RELATED ARTICLESMORE FROM AUTHOR Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism EMA Recommends Extension of Indications for Ponatinib Associated with a New Pharmaceutical Form and a New Strength MOST POPULAR Take with Food: Study Tests Lowering Dose of Prostate Cancer Drug April 23, 2018 Seven Extra Years July 2, 2022 How Cancer Survivors Can Overcome Common Challenges of Exercise After Treatment April 12, 2022 Age: the forgotten cancer risk factor? May 29, 2023 Load more HOT NEWS FDA Approves Pembrolizumab with Chemotherapy for Unresectable Advanced or Metastatic Malignant... NECTIN4 Amplification Predicts Response to Enfortumab Vedotin and Long-Term Survival in... Man Pushes Daughter To Safety Before Speeding Car Hits Him Instead:... Daratumumab Plus Bortezomib and Dexamethasone Regimen Significantly Prolongs OS in Patients...
